$CBDD - CBD OF DENVER, INC. (CBDD) Is Pleased to Announce a

New Post Public Reply Private Reply Replies (0) Message Board
Lets Roll
156
$CBDD - CBD OF DENVER, INC. (CBDD) Is Pleased to Announce a Reduction of Our Long Term Debt

https://www.marketwatch.com/press-release/cbd...quote_news
Consider all my posts my opinion and not advice to buy or sell anything. I post on stocks I own or am considering owning. Do your own DD!
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Tribal Tech Triumph: ILINX Boosts Proposal Efficiency

Updated Category News Views 97

A New Era for Tribal Operations Well, here's a headline that might've slipped under your radar, but it’s got some serious implications. Over in Olympia, Washington, ImageSource, Inc., the brains behind the ILINX platform, just scored a home run with an automated system for crafting Tribal Indirect Cost Rate Proposals (ICRPs). This ain't just gadget talk; this is a...

Continue Reading
Max Stock Gears Up for Q3 Earnings Report Nov. 17

Updated Category News Views 10

Max Stock's Q3 Earnings Anticipation Ah, it’s that time again—when we wait with bated breath for another round of quarterly earnings. Max Stock Ltd. (TASE: MAXO) is prepping to spill the beans on their third quarter 2026 performance, with a conference call scheduled for November 17. Big day? You bet. Who's Leading the Call? The brains behind the operation, CFO Paz Oz...

Continue Reading
Keeping Halloween Safe and Fun with AHN Tips

Updated Category News Views 131

Trick or Treat the Safe Way Ah, Halloween. A time when you don't just get to pretend to be someone else; you get to pile on the candy like it's a second job. But hold up! Before your pint-sized Dracula sprints into the foggy night, heed some wisdom from the folks at Allegheny Health Network. They aren't just offering another bowl of sugar-coated advice; they've got...

Continue Reading
BioMarin Strikes Deal for New Fabry Disease Therapy

Updated Category News Views 25

BioMarin's Latest Moves in Rare Disease Therapies Now here's a plot twist in the biotechnology landscape. BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) just did what they do best—snagging rights to a promising enzyme therapy aimed at turning the tide for Fabry disease. In a deal that spoke volumes about their intentions, BioMarin is forking over a cool $70 million upfront...

Continue Reading
Abbe Lane's Estate Auction: Glamour Up for Grabs

Updated Category News Views 72

Glamour from the Mid-Century Comes to the Auction Block In a world obsessed with the flavor of the month, a collection that truly turns heads by sailing in on a wave of genuine mid-century splendor isn't something you stumble upon every day. John Moran Auctioneers has the privilege to crack open the vault on the Estate of Abbe Lane, a name that once rolled off tongues...

Continue Reading
Factory-Built Homes Take Center Stage in New Doc Short

Updated Category News Views 109

Housing is one of those things we all think we understand until we start peeling back the layers of its history, especially when factory-built homes are involved. Here's a new angle: Clayton has just released the teaser for their documentary short, "Built: A Story of Factory-Built Housing in America," and it's turning the lights on a sector that's often left in the...

Continue Reading
Ashling's New Feat: Microsoft Recognition in AI

Updated Category News Views 0

Microsoft's Stamp of Approval for Ashling Ah, recognition—it's not just for egos. When Ashling, an AI consultancy heavyweight, gets a nod from Microsoft, it's worth more than a footnote in the company newsletter. This isn't some participation trophy. Nope, it's a badge saying they know their Data & AI, and Digital & App Innovation inside out. On October 29, 2026,...

Continue Reading
Genedata's New ELN Transforms Biopharma R&D Workflows

Updated Category News Views 58

Revolutionizing Research with a New Digital Tool Genedata, the brain behind enterprise software for drug discovery, has thrown a curveball into the world of biopharmaceutical research by launching a pioneering electronic lab notebook (ELN). This isn’t just another software update; it's a complete shift in how R&D workflows are structured and maintained. With an...

Continue Reading
LanguageLine AI App Earns Vizient Technology Kudos

Updated Category News Views 57

Tech Talk: LanguageLine's AI App Gains Important Recognition Diving headfirst into the chaotic world of healthcare, LanguageLine's AI Translation App earned a standout accolade. Just announced, it's snagged the Innovative Technology Designation from Vizient, the heavyweight champ in healthcare performance improvement. On the scene since the end of October, they rolled the...

Continue Reading
United Imaging Surges with 19.43% Revenue Growth in 2026

Updated Category News Views 18

United Imaging's Remarkable Revenue Surge Coming out of Shanghai, we've got some major numbers to chew on. United Imaging Healthcare (688271.SH)—this isn't your run-of-the-mill medical tech firm—is bringing some serious heat to the market with a 19.43% bump in revenue. We're talking RMB 10.58 billion raked in over just the first nine months of 2026. Those are hefty...

Continue Reading

Top 5 Most Recently Viewed Articles

Transforming Retail with Vantage and Quid's Unique Partnership

Updated Category News Views 245

Introduction to a New Era in Retail Intelligence In a rapidly evolving retail landscape, the partnership between Vantage Discovery and Quid marks a significant leap towards integrating advanced technology with consumer insights. Vantage Discovery, recognized for its cutting-edge AI-powered search and personalization solutions, is teaming up with Quid, a leader in trend...

Continue Reading
Ellington Financial Inc. Achieves Milestone in Non-QM Market

Updated Category News Views 195

Ellington Financial Inc. Celebrates Non-QM Securitization Success Ellington Financial Inc. (NYSE: EFC) has reached a significant milestone with the successful closing of a $288 million securitization, which is backed by a pool of non-qualified residential mortgage (non-QM) loans. This achievement underscores the Company’s commitment to innovating in the mortgage market....

Continue Reading
Ryman Hospitality Properties, Inc. Enhances Investor Insights

Updated Category News Views 124

Insights into Ryman Hospitality Properties, Inc. Ryman Hospitality Properties, Inc. (NYSE: RHP) is at the forefront of the hospitality and lodging industry, focusing on upscale group-oriented resorts and convention centers. This commitment to excellence enables the Company to provide memorable experiences, especially in country music entertainment. Updated Investor...

Continue Reading
Investing Insights: Understanding Your Rights as a Shareholder

Updated Category News Views 147

Understanding Your Rights as a Shareholder Shareholders should contact the firm immediately as there may be limited time to enforce your rights. Halper Sadeh LLC, an investor rights law firm, is currently investigating significant transactions involving certain public companies and their shareholders' rights. The firm primarily focuses on potential violations of federal...

Continue Reading
Bambusa Therapeutics Secures Series A-2 Financing to Boost Development

Updated Category News Views 337

Bambusa Therapeutics Completes Series A-2 Financing Successfully Bambusa Therapeutics, Inc., a prominent clinical-stage biotechnology firm specializing in next-generation bispecific antibodies for immunology and inflammation, has announced an important milestone: the completion of their oversubscribed Series A-2 financing. This achievement comes with a notable valuation...

Continue Reading